Related Experiment Video
Updated: May 24, 2026
10:34
Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
Gene expression changes in patients with fulminant type 1 diabetes
Zhen Wang1, Chao Zheng, Yu-Yu Tan
1Diabetes Center, Second Xiangya Hospital, and Institute of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, Changsha, Hunan 410011, China.
Chinese Medical Journal
|February 21, 2012
Summary
Fulminant type 1 diabetes (F1D) involves altered gene expression and reduced NK cell activity. Key genes like TLR9, ELF4, and IL1RAP may contribute to F1D by affecting beta-cell function.
Area of Science:
- Immunology
- Genetics
- Endocrinology
Background:
- Fulminant type 1 diabetes (F1D) is a complex autoimmune endocrine disorder.
- Understanding the molecular mechanisms of F1D is crucial for developing targeted therapies.
Purpose of the Study:
- To identify gene expression changes in peripheral blood mononuclear cells of F1D patients.
- To elucidate potential molecular pathways and mechanisms underlying F1D pathogenesis.
Main Methods:
- Microarray analysis of peripheral blood mononuclear cells from F1D patients and healthy controls.
- Real-time polymerase chain reaction (RT-PCR) for gene expression validation.
- Methyl thiazoleterazolium assay to assess Natural Killer (NK) cell activity.
Main Results:
- Microarray analysis revealed 759 differentially expressed genes between F1D patients and controls.
- Expression of TLR9, ELF4, and IL1RAP was confirmed, showing consistency with microarray findings.
- NK cell activity was significantly decreased in F1D patients, and affected genes were linked to IL-1 and TNF-α signaling pathways.
Conclusions:
- Gene expression alterations in TLR9, ELF4, and IL1RAP are implicated in F1D.
- NK cell dysfunction and dysregulation of IL-1 and TNF-α signaling pathways may contribute to F1D by inducing beta-cell dysfunction.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...